AI sleep care company gets $20M infusion

An artificial intelligence healthcare company that analyzes sleep data to diagnose such conditions as sleep apnea has received a $20 million investment to expand.

Advertisement

EnsoData said it plans to use the funding to expand its team, commercial distribution partnerships and product offerings. The Madison, Wis.-based company uses AI-assisted automated scoring systems to treat patients with sleep issues.

The series A extension was led by Inspire Medical Systems.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.